Sort   by:  
 Page size 
UnknownInteractive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell lines.
Not available
S-EPMC10356876 | biostudies-literature
UnknownKRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma.
Not available
S-EPMC7947421 | biostudies-literature
UnknownOutcomes of oncological intended thoracic surgery after lung transplantation.
Not available
S-EPMC11009586 | biostudies-literature
UnknownRecombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation.
Not available
S-EPMC4942037 | biostudies-literature
UnknownPrevalence of TERT Promoter Mutations in Orbital Solitary Fibrous Tumors.
Not available
S-EPMC10887834 | biostudies-literature
UnknownTherapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A Charite Comprehensive Cancer Centre analysis.
Not available
S-EPMC11661508 | biostudies-literature
UnknownStatus quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing.
Not available
S-EPMC8364534 | biostudies-literature
UnknownTargeted next-generation sequencing of circulating free DNA enables non-invasive tumor detection in myxoid liposarcomas.
Not available
S-EPMC8842903 | biostudies-literature
UnknownCurrent practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE study.
Not available
S-EPMC12605775 | biostudies-literature
Sort   by:  
 Page size